Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

SC 40230

Known as: SC-40230 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
SummaryWe investigated the antiarrhythmic effects of bidisomide (SC-40230), a new class I antiarrhythmic drug, in early-phase… Expand
  • table 1
  • figure 1
  • table 2
  • table 3
  • table 4
1999
1999
In this research the separation of the enantiomers of the basic drug bidisomide (SC‒40230) from five closely related known… Expand
1993
1993
Bidisomide is a Class Ia/Ib antiarrhythmic agent with activity against ventricular and supraventricular arrhythmias. The… Expand
1992
1992
Forty‐nine healthy male volunteers received the test article for bidisomide (SC‐40230) in a double‐blind, placebo‐controlled… Expand
1992
1992
Bidisomide (SC‐40230) is a class I antiarrhythmic agent. The effects of bidisomide on the electrophysiology of the intact heart… Expand
1989
1989
SC‐40230, α‐[2‐[acetyl(1‐methylethyl)amino]ethyl]‐α‐(2‐chlorophenyl)‐1‐piperidinebutanamide, a new class I antiarrhythmic agent… Expand
1989
1989
The cardiac and general haemodynamic effects of SC-40230, a newly developed anti-arrhythmic agent with both class 1a and 1b… Expand
1988
1988
Analogues of the dibasic antiarrhythmic agent disobutamide (2) were prepared and evaluated for antiarrhythmic efficacy… Expand